Amphastar Pharmaceuticals, Inc.
AMPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001297184
In the last 90 days, Amphastar Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 212 institutions reported holding it in 13F filings for Q2 2026, worth $572.1M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Amphastar Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 213 | 1 | 218 | +6 |
| Shares | 29.1M | 20.8K | 30.2M | +1.08M (+3.7%) |
| Value | $816.7M | $601.0K | $1.13B | +$316.8M (+38.8%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (32)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (26)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Pacer Advisors, Inc. | 231,009 | $6.47M |
| Qube Research & Technologies Ltd | 61,271 | $1.72M |
| Schroder Investment Management Group | 44,326 | $1.24M |
| Twinbeech Capital LP | 43,937 | $1.23M |
| Acadian Asset Management LLC | 23,870 | $668.0K |
| Occudo Quantitative Strategies LP | 23,213 | $650.4K |
| STRS Ohio | 18,300 | $512.0K |
| XTX Topco Ltd | 16,480 | $461.8K |
| Schonfeld Strategic Advisors LLC | 16,398 | $459.5K |
| ExodusPoint Capital Management, LP | 14,515 | $407.0K |
| Navellier & Associates Inc | 13,155 | $368.6K |
| Jupiter Asset Management Ltd | 13,128 | $367.1K |
| HSBC Holdings PLC | 10,370 | $288.7K |
| Kula Investments, LLC | 10,236 | $286.8K |
| DuPont Capital Management Corp | 2,980 | $83.5K |
| Point72 Middle East FZE | 1,782 | $49.9K |
| Sutton Wealth Advisors Inc. | 1,355 | $38.0K |
| Anfield Capital Management, LLC | 1,027 | $28.8K |
| Money Concepts Capital Corp | 602 | $16.9K |
| Ellevest, Inc. | 405 | $11.3K |
| Simplex Trading, LLC | 279 | $7.00K |
| Aua Capital Management, LLC | 28 | $785 |
| Sofos Investments, Inc. | 28 | $760 |
| Tfo-TDC, LLC | 6 | $457 |
| Rockefeller Capital Management L.P. | 14 | $0 |
| IFP Advisors, Inc | 18 | – |
Not filed for Q1 2023 yet (1)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Comerica Bank | 20,752 | $601.0K |